Lipella Pharmaceuticals CMO and Board Member Michael Chancellor to retire effective Dec 4, 2025

LIPELLA PHARMACEUTICALS INC.

Dr. Michael Chancellor notified intention to retire as Chief Medical Officer and Board member.
Retirement effective December 4, 2025; no disagreement with company cited.
Dr. Chancellor's departure planned and not due to policy or operational disputes.

item 5.02

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001753926-25-001602

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.